Bio-Rad Laboratories, Inc. Share Price NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 337.00 USD | +8.93% |
|
0.00% | +8.46% |
| 07-01 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 06-03 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
| Market Cap | 8.63B 7.5B 7B 6.43B 12.12B 822B 12.33B 82.56B 32.33B 410B 32.41B 31.69B 1,353B | P/E 2026 * |
39.1x | P/E 2027 * | 38.2x |
|---|---|---|---|---|---|
| Enterprise Value | 7.88B 6.85B 6.39B 5.87B 11.07B 751B 11.26B 75.39B 29.53B 375B 29.6B 28.94B 1,235B | EV / Sales 2026 * |
3.07x | EV / Sales 2027 * | 2.91x |
| Free-Float |
60.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +8.93% | ||
| Current month | +8.93% | ||
| 1 month | +14.87% | ||
| 3 months | +30.39% | ||
| 6 months | +31.10% | ||
| Current year | +8.46% |
| 1 month | 293.37 |  | 337 |
| Current year | 244.54 | | 337 |
| 1 year | 244.54 | | 337 |
| 3 years | 0 | | 373.78 |
| 5 years | 0 | | 818.6 |
| 10 years | 0 | | 818.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 31/12/2002 |
| President | 61 | 08/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 14/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 31/12/2011 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 24/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 24/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.93% | 0.00% | - | - | 8.63B | |
| +1.34% | +2.52% | -17.56% | -0.39% | 183B | |
| +1.51% | +2.92% | -3.30% | +2.59% | 109B | |
| -0.95% | -0.89% | +5.02% | +61.15% | 60.57B | |
| +2.37% | +2.85% | +44.34% | +56.22% | 51.8B | |
| +2.77% | +7.10% | -4.86% | -36.65% | 45.64B | |
| +3.03% | +1.94% | - | - | 33.22B | |
| +4.63% | +19.00% | +14.50% | -28.48% | 31.49B | |
| +2.05% | +5.04% | +45.95% | -5.89% | 24B | |
| +1.86% | +6.52% | +1.84% | +3.17% | 22.26B | |
| Average | +2.78% | +4.52% | +10.74% | +6.46% | 62.35B | |
| Weighted average by Cap. | +1.90% | +3.37% | +0.77% | +7.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.23B 2.08B 1.91B 3.61B 245B 3.67B 24.56B 9.62B 122B 9.64B 9.43B 402B | 2.63B 2.29B 2.14B 1.96B 3.7B 251B 3.77B 25.21B 9.87B 125B 9.9B 9.68B 413B |
| Net income | 225M 196M 183M 168M 316M 21.45B 322M 2.15B 843M 10.69B 845M 826M 35.28B | 230M 200M 187M 171M 323M 21.92B 329M 2.2B 862M 10.93B 864M 845M 36.06B |
| Net Debt | -749M -651M -608M -558M -1.05B -71.39B -1.07B -7.17B -2.81B -35.6B -2.81B -2.75B -117B | -965M -839M -783M -719M -1.36B -92.02B -1.38B -9.24B -3.62B -45.89B -3.63B -3.55B -151B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/08/26 | US$337.00 | +8.93% | 63 |
| 31/07/26 | US$0.000000 | - | 6 |
| 30/07/26 | US$0.000000 | - | 20 |
| 29/07/26 | US$0.000000 | - | 8 |
| 28/07/26 | US$0.000000 | - | 13 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
Select your edition
All financial news and data tailored to specific country editions
